Safety and efficacy of solifenacin in men with OAB [overactive bladder] and detrusor underactivity
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2008
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- 06 Jun 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 20 Sep 2007 The expected completion date for this trial is now 1 Jun 2007.
- 06 Apr 2007 New trial record.